Back to LYEL

BRIDGEWAY CAPITAL MANAGEMENT, LLC → LYEL

BRIDGEWAY CAPITAL MANAGEMENT, LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
4
Latest value
$246K
Q3 2026
Peak value
$554K
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$554K
Q1 2026$361K
Q2 2026$253K
Q3 2026$246K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$246K25.2K——
Q2 2026$253K18.0K——
Q1 2026$361K18.0K——
Q4 2025$554K18.0K——

Other funds holding LYEL

Other BRIDGEWAY CAPITAL MANAGEMENT, LLC positions

NVDA

NVIDIA CORPORATION

$61.3M
AAPL

APPLE INC

$56.5M
NVDA

NVIDIA CORPORATION

$56.3M
NVDA

NVIDIA CORPORATION

$52.1M
AMD

ADVANCED MICRO DEVICES INC

$52M
NVDA

NVIDIA CORPORATION

$48.6M
MSFT

MICROSOFT CORP

$48.5M
AMD

ADVANCED MICRO DEVICES INC

$47.7M